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Abstract
Background—Diabetes-associated cardiac dysfunction is associated with mitochondrial
dysfunction and oxidative stress, which may contribute to LV dysfunction. The contribution of
altered myocardial insulin action, independently of associated changes in systemic metabolism is
incompletely understood. The present study tested the hypothesis that perinatal loss of insulin
signaling in the heart impairs mitochondrial function.
Methods and Results—In 8-week-old mice with cardiomyocyte deletion of insulin receptors
(CIRKO), inotropic reserves were reduced and mitochondria manifested respiratory defects for
pyruvate that was associated with proportionate reductions in catalytic subunits of pyruvate
dehydrogenase. Progressive age-dependent defects in oxygen consumption and ATP synthesis with
the substrates glutamate and the fatty acid derivative palmitoyl carnitine (PC) were observed.
Mitochondria were also uncoupled when exposed to PC due in part to increased ROS production and
oxidative stress. Although proteomic and genomic approaches revealed a reduction in subsets of
genes and proteins related to oxidative phosphorylation, no reduction in maximal activities of
mitochondrial electron transport chain complexes were found. However, a disproportionate reduction
in TCA cycle and FA oxidation proteins in mitochondria, suggest that defects in FA and pyruvate
metabolism and TCA flux may explain the mitochondrial dysfunction observed.
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Conclusions—Impaired myocardial insulin signaling promotes oxidative stress and mitochondrial
uncoupling, which together with reduced TCA and FA oxidative capacity impairs mitochondrial
energetics. This study identifies specific contributions of impaired insulin action to mitochondrial
dysfunction in the heart.
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Metabolism; Mitochondria; Oxidative Stress; Insulin
INTRODUCTION
Recent studies have suggested that impaired mitochondrial energetics may contribute to cardiac
dysfunction in obesity and diabetes 1–7. The pathogenesis of mitochondrial dysfunction in
obesity or diabetes-related heart disease is likely multifactorial, but includes fatty acid mediated
mitochondrial uncoupling and oxidative damage 3, 4, 8–11. A commonly associated finding in
the heart in experimental models of obesity and diabetes is myocardial insulin resistance 12–
16. However it is not known if myocardial insulin resistance per se directly contributes to the
pathogenesis of myocardial mitochondrial dysfunction.
The effects of myocardial insulin signaling on the acute regulation of myocardial metabolism
is well known 17, 18, and includes increasing glucose uptake and glycolysis via regulation of
GLUT4 translocation19, 20 and activation of 6-phosphofructo-1-kinase (PFK-1) 21. In perfused
hearts, insulin increases glucose oxidation and reduces fatty acid (FA) oxidation13. In vivo, the
antilipolytic effect of insulin also reduces the delivery of free fatty acids (FFA) to the heart,
which further reduces myocardial FA oxidation 18. The direct effects of reduced insulin
signaling on myocardial substrate utilization are not well understood, in part because systemic
insulin deficiency or insulin resistance will increase the delivery of FA to the heart in vivo,
which will increase myocardial FA utilization and activate PPAR-alpha mediated
transcriptional pathways that further augment myocardial FA oxidative capacity 22. In contrast,
perinatal loss of insulin receptors in cardiomyocytes reduces myocardial glucose and FA
oxidation 23 suggesting that the direct effect of insulin deficiency on myocardial substrate
utilization is distinct from effects that are secondary to loss of insulin signaling in the periphery.
The present study sought to elucidate direct effects of impaired insulin action on cardiac
mitochondria in the absence of systemic metabolic disturbances that accompany insulin
resistance or insulin deficiency. Thus, we examined mitochondrial function in mice with
perinatal loss of insulin receptors in cardiomyocytes (CIRKO) to test the hypothesis that
impaired myocardial insulin action might contribute to mitochondrial dysfunction in the heart
in insulin resistant states. This study demonstrates that genetic deletion of insulin receptors in
cardiomyocytes impairs mitochondrial function via multiple mechanisms that include loss of
TCA cycle and beta-oxidation proteins, oxidative stress and mitochondrial uncoupling. Thus
impaired myocardial insulin signaling might directly contribute to mitochondrial dysfunction
in conditions such as obesity and diabetes.
MATERIALS AND METHODS
The authors have full access to and take full responsibility for the integrity of the data. All
authors have read and agree to the manuscript as written.
Generation of mice
Mice with cardiomyocyte-selective ablation of the insulin receptor (CIRKO), generated as
previously described 23 were fed standard chow (see supplementary materials for composition
of chow) and housed in temperature-controlled facilities with a 12-h light and 12-h dark cycle
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(lights on at 06:00). Animals were studied in the random fed state during the day (between
07:00 to 13:00) using protocols that were approved by the Institutional Animal Care and Use
Committee of the University of Utah.
Determination of cardiac function by echocardiography
Echocardiography was performed in lightly anesthetized (isoflurane) mice using a Vivid7
echocardiogram unit (General Electric, Tampa, Fl), by an investigator blinded to genotype and
analyzed as previously described 23–25.
Cardiac function MVO2 and substrate utilization in perfused mouse hearts
Retrograde heart perfusions were performed in 8-, 24- and 54- week-old mice as previously
described 3 with Krebs buffer containing (in mmol/l) 118 NaCl, 4.7 KCl, 25 NaHCO3, 1.2
MgSO4, 1.2 KH2PO4, 2 CaCl2, and 11 glucose gassed with 95% O2 and 5% CO2. Heart rates
were maintained at 360 beats/min by pacing at 6 Hz at the level of the atria. Oxygen
consumption was calculated as previously described 3. 8-week-old mouse hearts were also
subjected to calcium-induced inotropic stress using our previously described protocols 3.
Palmitate oxidation rates and MVO2 were determined in isolated working hearts as previously
described 13.
Mitochondrial respiration and ATP synthesis
Mitochondrial function (oxygen consumption and ATP synthesis rates) were studied in
saponin-permeabilized fibers as described 3, 4, 26, and in mitochondria isolated by differential
centrifugation 27 (see supplementary methods). Substrates used were: 5 mmol/l glutamate and
2 mmol/l malate, 10 mmol/l pyruvate and 5 mmol/l malate, or 20 µmol/l palmitoyl-carnitine
with 2 mmol/l malate. To evaluate maximal respiratory capacity of isolated mitochondria,
O2 consumption was determined in pyruvate-exposed mitochondria following treatment with
oligomycin (1µg/ml) and the addition of FCCP (carbonyl cyanide p-
trifluoromethoxyphenylhydrazone [0.7 µmol/l].
Mitochondrial fractionation
Isolated mitochondria were resuspended in 100µl 10 mmol/l Tris/HCl (pH 8.5) and subjected
to 3 freeze-thaw cycles using liquid nitrogen. Lysed mitochondria were centrifuged twice at
40,000×g for 20 min at 4°C. The supernatant (matrix fraction) and the pellet (membrane
fraction) were stored/suspended in 10 mmol/l Tris/HCl and maintained at −80°C until used for
proteome analysis by mass spectroscopy or Blue native-PAGE (membranes only). The
fractionation protocol yields a matrix fraction and a membrane fraction (containing outer and
inner mitochondrial membranes) that are enriched for respective representative proteins, with
minimal cross contamination (supplementary Figure S1).
Blue-native gel electrophoresis (BN-PAGE) and in-gel complex activities—BN-
PAGE was performed as described 28, with some modifications (see supplementary methods).
Mitochondrial Proteomics by Mass Spectrometry
Identification of differentially expressed mitochondrial matrix and membrane proteins was
achieved using liquid chromatography and mass spectroscopy (LC/MS/MS). Samples were
initially subjected to tryptic digestion prior to LC and parallel fragmentation MS. (See
supplementary methods).
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Hydrogen peroxide (H2O2) measurement
Mitochondrial H2O2 generation was measured as previously described 4 except that palmitoyl-
carnitine 60 µmol/l and L-carnitine 2 mmol/l were used as substrates.
Treatment of mice with the anti-oxidant (MnTBAP)
Four groups of mice were treated starting at 4-weeks of age. Wild-type and CIRKO mice (n =
12 per group) received twice-weekly intraperitoneal injections (20 mg/kg bodyweight) of the
cell-permeable superoxide dismutase (SOD) mimetic and peroxynitrite scavenger MnTBAP
(Mn (III) tetrakis (4-benzoic acid) porphyrin Chloride) (EMD Chemicals Inc. San Diego, CA)
for 4 weeks. Control wild-type and CIRKO mice (n = 12 per group) received twice-weekly
intraperitoneal injections of saline. After treatment, animals were euthanized and hearts
collected for determination of aconitase activity and oligomycin-insensitive respiration rates.
Western blot analysis
Western-blot analysis was performed using total heart or mitochondrial proteins as previously
described (see supplementary methods) 3.
Gene expression
Total RNA was extracted from ∼ 30mg heart tissue with Trizol reagent (Invitrogen
Corporation, Carlsbad, CA) and purified with the RNEasy Kit (Qiagen Inc., Valencia, CA).
Equal amounts of heart RNA from six mice were subjected to real-time PCR using an ABI
Prism 7900HT instrument (Applied Biosystems, Foster City, CA) in 384-well plate format
with SYBR Green I chemistry and ROX internal reference (Invitrogen) as previously described
4, 25. All reactions were performed in triplicate. Data were normalized to cyclophilin (CPHN).
See Supplementary Table S1 for Primer sequences.
Electron Microscopy
Ventricular samples were analyzed by electron microscopy and mitochondrial volume density
and number determined by stereology in a blinded fashion using the point counting method as
previously described 4, 29. For volume density, 2 images per sample were analyzed
(magnification 2,000X), using 2 grids per image. For mitochondrial number, 3 images per
sample were analyzed (magnification 8,000X).
Statistical Analysis
Data are means ± SEM. Comparisons of a single variable in ≥ 2 age-matched groups were
analyzed by one way ANOVA followed by Fisher’s least protected squares test (StatView 5.0.1
software, SAS Institute, Cary, NC). In analyses comparing ≥ 2 variables such mitochondrial
parameters in control and KO mice as a function of age, a general linear model (e.g. 2-way
ANOVA) was used. When significant differences existed across multiple ages, a Tukey-
Kramer multiple-comparison adjustment was performed on post-hoc comparisons to determine
at which ages the measures are different (SAS 9.0.3 software, SAS Institute, Cary, NC). For
all analyses p < 0.05 was considered significant. Unless specified, p values indicate statistically
significant difference between groups across all ages. When differences (by post-hoc analysis)
exist between ages these will be indicated in the figure legends. Proteomic data were analyzed
using previously published algorithms.30 in brief, the key algorithm in the Waters Protein
Expression System is the clustering algorithm, which chemically clusters peptide components
by mass and retention time for all injected samples and performs binary comparisons for each
experimental condition to generate an average normalized intensity ratio for all matched
AMRT (Accurate Mass, Retention Time) components. The Student’s t-test was used for each
binary comparison.
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RESULTS
Cardiac function
Cardiac function was determined by echocardiography and in isolated hearts. We previously
reported that fractional shortening (%FS) and +dP/dt (in vivo) were reduced by 20 and 30%
respectively in 10-week-old CIRKO mice 25. Thus we determined in vivo cardiac function at
later ages. Fractional shortening was reduced by 17% and 7% respectively in CIRKO hearts
relative to controls at 27 and 67-weeks of age (Table 1). In glucose-perfused Langendorff hearts
functional parameters declined with age in CIRKO and control hearts. However, developed
pressure, rate pressure product (RPP) and cardiac efficiency were always signigicantly reduced
in CIRKO hearts at the three ages examined (8, 24 and 54-weeks) (Table 2). Differences in
cardiac function between 8-week-old CIRKO and control mice were accentuated under
conditions of calcium-induced inotropic stress (Supplementary Figure S2).
Mitochondrial Dysfunction in CIRKO Mice
Mitochondrial oxygen consumption and ATP production rates in cardiac fibers from 8-, 24-
and 54-week-old CIRKO mice were examined. With glutamate as substrate, maximal ADP-
stimulated mitochondrial respirations (VADP) progressively declined with age (Figure 1A). At
8-weeks, CIRKO mice exhibited reduced VADP with pyruvate, which persisted up to 54 weeks,
and was associated with lower ATP synthesis rates in older animals (24 to 54 weeks) (Figure
1B and H). With palmitoyl-carnitine (PC), VADP, was initially increased in 8-week-old mice,
but progressively declined with age (Figure 1C). The increased PC respirations at 8-weeks was
not associated with increased ATP synthesis rates (Figure 1I). By 24-weeks, ATP synthesis
rates declined by 60% and the ATP/O ratio declined by 50% compared to controls (Figure 1I).
Thus mitochondria from CIRKO hearts manifest 2 distinct functional defects: (1) reduced
respiratory capacity and ATP generation with all substrates, and (2) evidence for mitochondrial
uncoupling (decreased ATP/O) when exposed to a FA substrate.
To confirm the existence of FA–induced mitochondrial uncoupling, studies with pyruvate or
PC-treated isolated mitochondria from 24-week-old mice were performed (Figure 2 A–D and
Supplementary Figure S3). Respiration rates in isolated mitochondria are approximately 10-
fold higher than in permeabilized fibers. Under these conditions the reduction in pyruvate
respirations was no longer apparent in CIRKO mitochondria and there were no differences in
oligomycin – insensitive (Voligo) respiration or respiratory control ratios (RCR). In contrast,
in the presence of the FA substrate PC, Voligo was increased by 1.3-fold and the RCR was
proportionately reduced by 33%. Moreover, ATP and ATP/O ratios were reduced, supporting
the existence of FA-induced mitochondrial uncoupling.
To determine if reduced electron transport chain (ETC) function accounted for mitochondrial
respiratory impairment, oligomycin-treated mitochondria were maximally stimulated by
exposure to an uncoupling agent FCCP. Under these conditions oxygen consumption rates are
independent of ATP synthesis and reflect maximal ETC capacity. There were no differences
between 24-week-old CIRKO and control mitochondria (Supplementary Figure S3). We
independently determined in-gel complexes I, IV and V activities, following separation of
mitochondrial membrane proteins by blue-native gel electrophoresis. No differences in ETC
activity were observed at any age (Figures 2 E–G).
Mitochondrial Proteins, Gene Expression and Mitochondrial Enzyme Activities
We also tested the hypothesis that defective mitochondrial function may result from changes
in the content or activity of enzymes involved in intermediary mitochondrial metabolism that
provide reducing equivalents to ETC. First, we conducted a proteome expression analysis of
mitochondrial membrane and matrix compartments (Table 3 A, B and supplementary table
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S2A, B). 93 mitochondrial matrix and 151 mitochondrial membrane proteins were identified.
In the mitochondrial matrix, 24 proteins were reduced in CIRKO mice relative to controls. Of
these proteins, 10 were involved in FA oxidation, 10 were involved in the TCA cycle and 3
represented subunits of pyruvate dehydrogenase (PDH) (specifically the E1 subunit and the
lipoamide beta subunit). In contrast, only 10 largely unrelated proteins were increased in the
matrix compartment (Table 3A, B and Supplementary Table S2A, B). In the mitochondrial
membrane fraction, FA oxidation proteins were also coordinately reduced, but the pattern for
OXPHOS proteins was more variable. For example, protein subunits of complex I, IV and V
were increased, whereas Cytochrome C isoforms and subunits of complex III were reduced.
Second, we examined enzyme activities as a function of age, focusing on the TCA enzyme
citrate synthase (CS), and the FAO regulatory enzymes, carnitine palmitoyl transferase-1
(CPT1) and 3-HydroxyAcyl-CoA dehydrogenase (HADH). Relative to age-matched controls,
CS activity progressively declined with age in CIRKO mice (Supplementary Figure S4).
Similarly, CPT1 and HADH activities, which were slightly enhanced at 8 weeks, also declined
with age in CIRKO mice relative to their age matched controls (Supplementary Figure S4).
Third, we conducted a focused analysis of the expression of nuclear-encoded mitochondrial
genes and confirmed global reduction in expression of genes involved in cellular and
mitochondrial FA uptake and beta-oxidation and reduced expression of their transcriptional
regulator PPAR-α (Table 4, and supplementary Figure S5). The mRNA of the E1α1 subunit
of PDH was reduced by 27%. In contrast, genes that regulate mitochondrial biogenesis were
essentially unaltered with the exception of SIRT1 (a potential regulator of PGC-1α activity)
whose expression was reduced by 31%. Consistent with the proteomic analysis, expression of
the subunit of complex III (Uqcrc1) was reduced by 20–30% (P < 0.05), whereas the expression
of the complex I subunit (Ndufa9) was not statistically different from controls. Uncoupling
protein expression (UCP2 and UCP3) was not increased, despite evidence of mitochondrial
uncoupling. Pyruvate dehydrogenase kinase (PDK4) expression was reduced in 8- and 24-
week old mice remdering it unlikely that reduced pyruvate flux resulted from increased
phosphorylation of the E1 subunit of the PDH complex. This was confirmed by blotting for
phosphorylated PDHE1, which was not altered in CIRKO hearts (Supplementary Figure S6).
Contribution of Increased Oxidative Stress to Mitochondrial Phenotypes of CIRKO Mice
To test the hypothesis that oxidative stress contributed to mitochondrial dysfunction and
mitochondrial uncoupling, we measured H2O2 generation and the activity of mitochondrial
aconitase, whose activity is susceptible to oxidative stress 31. Mitochondrial Aconitase activity
was reduced by 38% and 47% in 8- and 24-week-old CIRKO mice respectively (Figure 3A),
in the absence of proportionate differences in aconitase protein levels (data not shown).
H2O2 production was increased by 15% and 28% in 8 and 24-week-old CIRKO mice
respectively versus age-matched controls (Figure 3B), following exposure to PC. Manganese
superoxide dismutase (Mn-SOD) and catalase protein expression were not significantly
different between CIRKO and wild-type mice at 8 weeks (data not shown). These data support
the hypothesis that increased mitochondrial ROS production could be an early or primary defect
in CIRKO mitochondria.
To test the hypothesis that reactive oxygen species may contribute to the increased uncoupling
in 8 week-old CIRKO (as evidenced by increased VADP without an accompanying increase in
ATP synthesis and increased oligomycin-insensitive respirations -VOligo), we treated CIRKO
mice with the superoxide dismutase mimetic (MnTBAP) for 4 weeks starting at 4-weeks of
age. Treatment with MnTBAP reversed the decline in aconitase activity both in the cytosolic
(data not shown) and mitochondrial fractions (Figure 3C) and prevented the increase in
VOligo in cardiac fibers from 8 week-old CIRKO mice (Figure 3D). These data suggest that
ROS may be partially responsible for mitochondrial uncoupling in CIRKO mouse hearts.
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Insulin Signal Transduction
PI3K signaling modulates mitochondrial FA oxidative capacity 32. Thus we determined if
differences in PI3K signaling pathways contribute to the mitochondrial phenotypes observed.
CIRKO mice exhibited a significant increase in the expression of IGF-1 receptors. Moreover,
there was no reduction in basal levels of Akt and GSK3β phosphorylation, which trended
higher. Whereas insulin stimulation significantly increased Akt and GSK3β phosphorylation
in the control hearts, no statistical increase in either Akt or GSK3β phosphorylation following
perfusion of CIRKO hearts with 1nM insulin was observed (Supplementary Figure S7).
Mitochondrial Number and Ultrastructure are Altered in CIRKO Mice
Mitochondrial morphology was normal in younger CIRKO mouse hearts but at 54 weeks they
appeared dysmorphic with reduced crista density (Figure 4A). Mitochondrial number and
volume density were increased at all ages examined (Figure 4 B, C). These changes occurred
despite the absence of any increase in expression of genes involved in mitochondrial biogenesis
and mitochondrial DNA replication such as peroxisome proliferator activated receptor gamma
co-activators α and β (PGC1α, PGC1β) and nuclear respiratory factors (NRF1 or NRF2).
Indeed, Transcription factor A-mitochondrial (TFAM) expression was reduced in 3-week-old
mice (Table 4).
DISCUSSION
Perinatal loss of insulin signaling in cardiomyocytes impairs mitochondrial function. There is
an early defect in pyruvate utilization and progressive reduction in mitochondrial oxidative
capacity and ATP synthesis with glutamate and palmitoyl carnitine substrates. There is a
modest decline in cardiac contractility at an early age, which does not progress to heart failure,
however cardiac function was significantly impaired in vitro following calcium-induced
inotropic stress. Two mechanisms for mitochondrial dysfunction were identified. First, there
was a coordinate reduction in TCA and FA enzymes that presumably impaired the delivery of
reducing equivalents to the electron transport chain, which remained functionally competent.
Second, mitochondria from insulin receptor deficient myocytes were more susceptible to FA-
induced oxidative stress and mitochondrial uncoupling. These changes promote a
mitochondrial biogenic response that occurs in the absence of increased PGC-1α expression.
These data identify an important role for insulin signaling pathways in modulating
mitochondrial bioenergetics and integrity. We recently reported that PI3K signaling regulates
mitochondrial function in the heart 32. The present study now shows that insulin signaling per
se also regulates myocardial mitochondrial oxygen consumption and ATP synthesis rates. The
blunted activation of PI3K targets such as Akt and its downstream substrate GSK3β in insulin-
perfused CIRKO hearts is consistent with the hypothesis that reduced PI3K signaling could
contribute to mitochondrial dysfunction in CIRKO hearts. However, given that basal levels of
phosphorylation of these kinases were not reduced, it is also likely that PI3K or Akt –
independent signals downstream of the insulin receptor also play an important role.
The mitochondrial defect appears initially to be specific for pyruvate utilization and
subsequently for FA utilization. These observations provide a mechanistic basis for our
previously published observations that in isolated perfused working hearts from 16–20- week-
old CIRKO mice, rates of glucose and FA oxidation were both reduced 23. An important
mechanism for reduced pyruvate flux appears to be reduced content of two key subunits of the
pyruvate dehydrogenase complex. The E1-alpha subunit is a key regulator of PDH flux and is
the substrate of the regulatory kinase PDK4 33, 34. We provide novel evidence that the E1α1
subunit of PDH may be an insulin-regulated transcript in the heart, and that reduced protein
levels of this subunit in mitochondrial matrix might occur on the basis of transcriptional
repression. Increased phosphorylation of the E1-alpha subunit by PDK4, decreases its stability,
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while blocking degradation of the E1-alpha subunit of PDH increases the activity of and flux
through the enzyme complex 35. However PDHE1 phosphorylation was not increased in
CIRKO hearts and the expression of its kinase (PDK4) was actually reduced. Mitochondrial
dysfunction in CIRKO mice is associated with modest reduction in cardiac function. We
previously reported that cardiac function was reduced in isolated working hearts that were
perfused with glucose and FA as substrates under normal workload 23. In the present study we
chose to study glucose perfused hearts because of the defect in pyruvate utilization in
mitochondria. We reasoned that in the presence of glucose alone, contractile dysfunction
following calcium-induced inotropic stress would be amplified.
We speculate that an early defect in glucose/pyruvate metabolism could initially lead to the
increase in FA utilization that was observed in the mitochondria of 8-week-old CIRKO mice.
However, this cannot be sustained over time because of the coordinate reduction in levels of
mitochondrial beta-oxidation enzymes. This hypothesis is also supported by the observation
of increased rates of FA oxidation (FAO) in isolated working hearts obtained from 8-week-
old CIRKO mice (see supplementary Figure S8) but reduced FAO in 16–20-week-old mice
23. The reduction in gene and protein expression levels of a broad array of regulators of FA
metabolism was striking, and extends our previously reported findings that demonstrated
reduced mRNA for acyl CoA dehydrogenases. The likely mechanism for these changes is
insulin-mediated regulation of expression levels of the PPAR-α gene in the heart.
The second major mechanism that contributed to mitochondrial dysfunction is oxidative stress
and ROS-mediated mitochondrial dysfunction. Increased ROS production was evident in the
hearts of 8-week-old CIRKO mice and was sufficient to reduce the activity levels of the redox
sensitive enzyme aconitase. This increase in ROS, also likely reduced mitochondrial energetics
by promoting mitochondrial uncoupling as evidenced by reduced ATP/O ratios in palmitoyl
carnitine treated mitochondria and increased oligomycin-insensitive respiration rates that were
normalized by treating animals with the antioxidant MnTBAP. MnTBAP reduces ROS but
could increase H2O2 generation, underscoring that mitochondrial superoxide likely mediates
the changes observed. Increased ROS could reflect changes in superoxide generation or
detoxification. Although, increased FA flux could contribute to increased ROS production in
8-week-old CIRKO hearts it is unlikely to represent the mechanism in older hearts in which
FA oxidation is reduced. Proteomic analysis revealed changes in stoichiometry of ETC
subunits, which could potentially contribute to increased superoxide generation. A major role
for a reduction in ROS degradation pathways as a contributor to increased H2O2 production
in CIRKO mitochondria appears unlikely, as neither MnSOD levels nor catalase content were
changed in 8-week-old mice and in 24-week-old animals, catalase content was marginally
lower. However it is possible that reduced TCA flux could limit the supply of reducing
equivalents to replenish NADPH pools that maintain antioxidants such as glutathione in the
reduced state. Taken together, deficient insulin signaling in the heart likely promotes
mitochondrial oxidative stress by multiple mechanisms.
Mitochondrial biogenesis has been described in the hearts of insulin resistant mice and has
been attributed to activation of PGC-1α-mediated signaling 36. Here we show that
mitochondrial number and volume density increased in CIRKO mice despite the lack of
coordinate changes in mRNA levels of key regulators of the mitochondrial biogenesis pathway
such as PGC-1α. Thus, the possibility exists that this proliferative response in CIRKO hearts
is a consequence of reduced ATP generation or increased oxidative stress that promote
mitochondrial biogenesis. In this regard it is important to discuss the discrepancy between
citrate synthase (CS) activities and increased mitochondrial volume density in aging CIRKO
mice. CS activity is widely used as an indirect estimate of mitochondrial mass. However, in
CIRKO mice, our proteomic analyses indicate CS protein content in mitochondrial matrix was
already significantly lower in 8-week-old CIRKO mice. This observation therefore supports
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the notion that the morphological “biogenic” response that we observed represents an
adaptation to pre-existing mitochondrial dysfunction in this model.
In conclusion, we demonstrate that insulin signaling is a regulator of mitochondrial oxidative
capacity via mechanisms that may determine TCA cycle flux and the mitochondrial metabolism
of pyruvate and fatty acids. Moreover, impaired insulin signaling predisposes cardiac
mitochondria to oxidative stress, which not only might damage mitochondria, but also impairs
energetics by activating mitochondrial uncoupling. Thus insulin signaling plays an essential
role in the maintenance of mitochondrial homeostasis in the heart. Given the perinatal timing
of insulin receptor deletion in CIRKO hearts, it is important to note that metabolic maturation
of the heart continues to occur throughout the neonatal period, thus we cannot rule out that the
phenotypes that we have observed might reflect unique effects of insulin resistance during this
important developmental window. Future studies in mice with inducible KO of insulin
receptors in adult hearts will be required to clarify this.
Diabetes and obesity are independent risk factors for the development of heart failure 37. There
is a growing body of evidence that acquired defects in insulin signaling, which may impair
cardiac metabolism and are associated with LV dysfunction, develop in the heart in diabetes
and obesity 38. The present study provides new insights into potential mechanisms linking
impaired post-natal insulin signaling with the development of mitochondrial dysfunction in
the heart.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Age-dependent changes in mitochondrial respiration and ATP synthesis rates in CIRKO
and wild-type mice
(Data are means±SEM).
(A), (D) and (G): VADP, VOligo, ATP synthesis rates and ATP/O ratio in the presence of
glutamate-malate in 8- (n=4), 24- (n=4) and 54- (n=5) week-old CIRKO (black bars) and wild-
type (WT) (white bars) respectively. Statistics (2-Way ANOVA): Panel A: VADP –WT vs.
CIRKO, p<0.01, 54-weeks vs. 8-weeks, p<0.01, 24-weeks vs. 54-weeks, P=0.06. Panel D and
G: No statistical differences between groups.
(B), (E), and (H) Same as (A), (D), (G) but in the presence of pyruvate-malate. Statistics (2-
Way ANOVA): Panel B: VADP – WT vs. CIRKO, p<0.005; Panel E: VOligo – 54-weeks vs.
24 or 8-weeks, p<0.01; Panel H: ATP – WT vs. CIRKO, p<0.05.
(C), (F), and (I) Same as (A), (D), (G) but in the presence of palmitoyl-carnitine and malate.
Statistics (2-Way ANOVA): Panel C: VADP – WT vs. CIRKO (at all ages), p<0.05, Decline
in CIRKO with age (p<0.005, after multiple comparison adjustments). Panel F: VOligo – WT
vs. CIRKO (at 8-weeks), p<0.005, Increase in WT with age (p<0.005, after multiple
adjustments). Panel I: ATP – WT vs. CIRKO, p<0.01 and p<0.05 at 24 and 54-weeks
respectively. ATP/O – WT vs. CIRKO, p<0.01.
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Figure 2. Mitochondrial function and electron transport chain complex activity
(A) and (B) Respiration traces of mitochondria (0.4 mg/ml) isolated from 24-week-old wild-
type (n = 5) and CIRKO mice (n = 5) respectively, using palmitoyl-carnitine as substrate.
(C) and (D) ATP and ATP/O ratio (means±SEM) measured on isolated mitochondria from
wild-type and CIRKO mice at 24-weeks of age using palmitoyl-carnitine as substrate.
(E) Representative blue-native polyacrylamide gel electrophoresis (BN-PAGE) Arrows
indicate separation of complexes I, II, III, IV, and V.
(F) and (G) Representative in-gel complex activity stainings, and densitometric quantification
(means±SEM) of complex I, IV, and V activities, of wild-type and CIRKO mice at 8- and 76-
weeks of age (n = 4 – 5).
* p < 0.05 vs. age-matched wild-type controls.
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Figure 3. Increased oxidative stress in CIRKO hearts
(Data are means±SEM).
A) Aconitase activity measured in mitochondria isolated from 8- and 24-week-old CIRKO
(black bars, n=5) and wild-type (white bars, n=6) hearts. Statistics (2-Way ANOVA): WT vs.
CIRKO, p<0.05 and p<0.005 at 8 and 24-weeks respectively.
B) Hydrogen peroxide (H2O2) production in isolated mitochondria obtained from 8 and 24-
week-old CIRKO (n=7) and wild-type (n=7). Mitochondria were incubated with palmitoyl-
carnitine and L–carnitine in the presence of oligomycin as described in the methods. Statistics
(2-Way ANOVA): WT vs. CIRKO, p<0.005
C) Mitochondrial aconitase activity determined in saline-treated wild-type (open bars, n=6 per
group), and CIRKO mice (black bars, n=6), and MnTBAP-treated wild-type (dotted bars, n=6)
and CIRKO mice (hatched bars, n=6), age 8-weeks.
D) Oligomycin-insensitive respiration (Voligomycin) in saponin-permeabilized cardiac fibers
from wild-type (saline and MnTBAP) and CIRKO mice (saline and MnTBAP), age 8-weeks.
* p<0.05, ** p < 0.005 versus wild-type; a p < 0.005 versus CIRKO saline; b p < 0.005 versus
wild-type MnTBAP (1-Way ANOVA).
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Figure 4. Mitochondrial number and morphology in CIRKO and wild-type hearts
A) Representative electron micrographs of heart sections (80–100 nm) from 3-, 8-, 24-, and
54-week-old wild-type (1, 2, 3 and 4) and CIRKO (5, 6, 7 and 8) mice (three per group).
B) Quantification of mitochondrial number in CIRKO hearts (fold change vs. wild-type
normalized to 1±SEM). Statistics (2-Way ANOVA): WT vs. CIRKO, p<0.005.
C) Mitochondrial volume density relative to cell area in wild-type and CIRKO mice at 8- and
24-weeks of age. Statistics (2-Way ANOVA): WT vs. CIRKO, p<0.005.
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Table 1
In-vivo cardiac function measured by echocardiography
27 week-old 67 week-old
Wild-type (n=7) CIRKO (n=8) Wild-type (n=5) CIRKO (n=5)
LVDd. (cm)a 0.39 ± 0.01 0.39 ± 0.007 0.42 ± 0.01 0.41 ± 0.01
LVDs. (cm) 0.27 ± 0.01 0.30 ± 0.008 0.31 ± 0.02 0.31 ± 0.006
IVSd. (cm)b 0.08 ± 0.004 0.07 ± 0.003 0.08 ± 0.005 0.07 (0.003
IVSs. (cm) 0.10 (0.01 0.10 (0.003 0.12 (0.008 0.10 (0.005
PWd. (cm) 0.08 (0.006 0.07 (0.003 0.08 (0.004 0.07 (0.003
PWs. (cm) 0.11 (0.004 0.10 (0.003 0.11 (0.007 0.10 (0.003
% FSb 29.40 (1.75 24.43 (0.91 25.95 (2.49 24.09 (1.3
EFb 0.64 (0.02 0.56 (0.01 0.58 (0.04 0.56 (0.02
HR. (beats/min) 455 ± 31 474 ± 15 460 ± 16 443 ± 23
SV. (ml) 0.03 ± 0.003 0.03 ± 0.002 0.04 ± 0.003 0.04 ± 0.004
CO. (ml/min) 17.29 ± 1.54 17.02 ± 0.92 20.45 ± 1.06 18.34 ± 2.22
Values are mean ± SEM.
a
p<0.05, 27-week vs. 67-week (both genotypes respectively)
b
p<0.05, Wild-type vs. CIRKO (both ages), by 2-way ANOVA. LVDd: left ventricular dimension in diastole; LVDs: left ventricular dimension in systole;
IVSd: inter-ventricular septum in diastole; IVSs: inter-ventricular septum in systole; PWd: posterior wall of left ventricle in diastole; PWs: posterior wall
of left ventricle in systole; FS: fractional shortening; EF: ejection fraction; HR: heart rate; SV: stroke volume; CO: cardiac output.
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Table 3
Table 3A: Proteomic Analysis of Mitochondrial Membrane Proteins in CIRKO Mice.
Protein Fold Change CIRKO/WT
(p<0.05)
Pathway
solute carrier family 25 (mitochondrial carrier, adenine
nucleotide translocator), member 13
1.16 ADP/ATP Translocase
solute carrier family 25 (mitochondrial carrier, phosphate
carrier), member 3
1.08 ADP/ATP Translocase
solute carrier family 25, member 5 1.05 ADP/ATP Translocase
glutamate oxaloacetate transaminase 2, mitochondrial 0.92 Amino Acid metabolism/anapleurosis/TCA
PREDICTED: similar to Aspartate aminotransferase,
mitochondrial precursor (Transaminase A) (Glutamate
oxaloacetate transaminase 2)
0.93 Amino Acid metabolism/anapleurosis
electron transferring flavoprotein, dehydrogenase 0.86 Electron Transfer to Complex II
2,4-dienoyl CoA reductase 1, mitochondrial 0.86 FA beta-oxidation
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-
oxoacyl-Coenzyme A thiolase)
0.83 FA beta-oxidation
acetyl-Coenzyme A dehydrogenase, long-chain [Mus
musculus]
1.14 FA beta Oxidation
acyl-CoA synthetase long-chain family member 1 0.87 FA beta-oxidation
acyl-Coenzyme A dehydrogenase, very long chain 0.80 FA beta-oxidation
carnitine acetyltransferase 0.79 FA beta-oxidation
carnitine palmitoyltransferase 2 0.68 FA beta-oxidation
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), alpha subunit
0.90 FA beta-oxidation
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), beta subunit
0.76 FA beta-oxidation
PREDICTED: similar to acyl-CoA synthetase long-chain
family member 1 isoform 4
0.88 FA beta-oxidation
PREDICTED: similar to acyl-CoA synthetase long-chain
family member 1 isoform 5
0.88 FA beta-oxidation
PREDICTED: similar to hydroxyacyl-Coenzyme A
dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-
Coenzyme A hydratase (trifunctional protein), beta subunit
0.75 FA beta-oxidation
dihydrolipoamide S-acetyltransferase (E2 component of
pyruvate dehydrogenase complex) [Mus musculus]
1.19 Glucose Oxidation
pyruvate dehydrogenase (lipoamide) beta 1.12 Glucose Oxidation
3-oxoacid CoA transferase 1 [Mus musculus] 1.23 Ketone Metabolism
Tu translation elongation factor, mitochondrial 1.2 Mitochondrial Chaperone, Mitochondrial protein translation
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9
[Mus musculus]
1.12 OXPHOS complex I
NADH dehydrogenase (ubiquinone) Fe-S protein 1 1.11 OXPHOS complex I
NADH dehydrogenase (ubiquinone) Fe-S protein 6 1.18 OXPHOS complex I
PREDICTED: similar to NADH dehydrogenase (ubiquinone)
Fe-S protein 3
1.11 OXPHOS complex I
PREDICTED: similar to NADH dehydrogenase (ubiquinone)
Fe-S protein 6
1.23 OXPHOS complex I
cytochrome c-1 0.87 OXPHOS complex III
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Table 3A: Proteomic Analysis of Mitochondrial Membrane Proteins in CIRKO Mice.
Protein Fold Change CIRKO/WT
(p<0.05)
Pathway
ubiquinol cytochrome c reductase core protein 2 0.94 OXPHOS complex III
cytochrome c oxidase subunit IV isoform 1 [Mus musculus] 1.09 OXPHOS complex IV
ATP synthase, H+ transporting, mitochondrial F1 complex,
alpha subunit, isoform 1
0.96 OXPHOS complex V
ATP synthase, H+ transporting, mitochondrial F1 complex,
delta subunit precursor [Mus musculus]
1.08 OXPHOS complex V
ATP synthase, H+ transporting, mitochondrial F1 complex,
gamma subunit [Mus musculus]
1.09 OXPHOS complex V
cytochrome c, somatic 0.87 OXPHOS cytochrome c
PREDICTED: similar to Cytochrome c, somatic 0.87 OXPHOS cytochrome c
PREDICTED: similar to Cytochrome c, somatic isoform 1 0.87 OXPHOS cytochrome c
PREDICTED: similar to Cytochrome c, somatic isoform 2 0.87 OXPHOS cytochrome c
creatine kinase, mitochondrial 1, ubiquitous 0.84 Phospho-transfer
creatine kinase, mitochondrial 2 0.76 Phospho-transfer
nicotinamide nucleotide transhydrogenase 1.23 Proton Transport and NADPH Regeneration
citrate synthase-like protein [Mus musculus] 1.12 TCA
dihydrolipoamide S-succinyltransferase (E2 component of 2-
oxo-glutarate complex) [Mus musculus]
1.19 TCA
isocitrate dehydrogenase 2 (NADP+), mitochondrial [Mus
musculus]
1.43 TCA
malate dehydrogenase 2, NAD (mitochondrial) 0.93 TCA
oxoglutarate dehydrogenase (lipoamide) 1.12 TCA (ROS production)
heat shock protein 9A [Mus musculus] 1.27 Unknown
hypothetical protein LOC237880 [Mus musculus] 1.16 Unknown
Table 3B: Proteomic Analysis of Mitochondrial Matrix Proteins from CIRKO Mice.
Protein Fold Change CIRKO/WT
(p<0.05)
Pathway
glutamate oxaloacetate transaminase 2, mitochondrial 0.88 Amino Acid metabolism/anapleurosis/TCA
PREDICTED: similar to Aspartate aminotransferase,
mitochondrial precursor (Transaminase A) (Glutamate
oxaloacetate transaminase 2)
0.88 Amino Acid metabolism/anapleurosis/TCA
acetyl-Coenzyme A acyltransferase 2 (mitochondrial 3-
oxoacyl-Coenzyme A thiolase)
0.74 FA beta-oxidation
acetyl-Coenzyme A dehydrogenase, long-chain 0.89 FA beta-oxidation
acetyl-Coenzyme A dehydrogenase, medium chain 0.76 FA beta-oxidation
acyl-Coenzyme A dehydrogenase, short chain 0.71 FA beta-oxidation
acyl-Coenzyme A dehydrogenase, very long chain 1.52 FA beta-oxidation
dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-
Coenyme A isomerase)
0.77 FA beta-oxidation
enoyl Coenzyme A hydratase, short chain, 1, mitochondrial 0.88 FA beta-oxidation
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-
Coenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), beta subunit
1.37 FA beta-oxidation
L-3-hydroxyacyl-Coenzyme A dehydrogenase, short chain 0.70 FA beta-oxidation
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Table 3B: Proteomic Analysis of Mitochondrial Matrix Proteins from CIRKO Mice.
Protein Fold Change CIRKO/WT
(p<0.05)
Pathway
PREDICTED: similar to hydroxyacyl-Coenzyme A
dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-
Coenzyme A hydratase (trifunctional protein), beta subunit
1.33 FA beta-oxidation
electron transferring flavoprotein, alpha polypeptide 0.89 FA metabolism
electron transferring flavoprotein, beta polypeptide 0.94 FA metabolism
thioesterase superfamily member 2 0.59 FA metabolism
PREDICTED: similar to Pyruvate dehydrogenase E1
component alpha subunit, somatic form, mitochondrial
precursor (PDHE1-A type I) isoform 2
0.76 Glucose oxidation
pyruvate dehydrogenase (lipoamide) beta 0.86 Glucose oxidation
pyruvate dehydrogenase E1 alpha 1 0.75 Glucose oxidation
3-oxoacid CoA transferase 1 1.23 Ketone Metabolism
inner membrane protein, mitochondrial 1.28 (Mitofillin) Required for normal mitochondrial inner membrane
morphology
PREDICTED: similar to coiled-coil-helix-coiled-coil-helix
domain containing 3 isoform 2
1.28 Mitofillin binding partner
ATP synthase, H+ transporting mitochondrial F1 complex,
beta subunit
1.37 OXPHOS complex V
ATP synthase, H+ transporting, mitochondrial F1 complex,
alpha subunit, isoform 1
1.37 OXPHOS complex V
aconitase 2, mitochondrial 0.92 TCA
aldehyde dehydrogenase family 6, subfamily A1 0.83 TCA
citrate synthase 0.9 TCA
fumarate hydratase 1 0.92 TCA
isocitrate dehydrogenase 2 (NADP+), mitochondrial 1.06 TCA
isocitrate dehydrogenase 3 (NAD+) alpha 0.78 TCA
oxoglutarate dehydrogenase (lipoamide 0.77 TCA
PREDICTED: similar to Malate dehydrogenase,
mitochondrial precursor
0.87 TCA
succinate-Coenzyme A ligase, ADP-forming, beta subunit 0.61 TCA
PREDICTED: similar to 60 kDa heat shock protein,
mitochondrial precursor (Hsp60) (60 kDa chaperonin)
(CPN60) (Heat shock protein 60) (HSP-60) (Mitochondrial
matrix protein P1) (HSP-65)
0.8 Unknown
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Table 4
Relative changes in gene expression in CIRKO and wild-type mice
Wild-type CIRKO
3 weeks
CIRKO
8 weeks
CIRKO
14–24 weeks
Fatty acid Metabolism
ACADM (MCAD) 1 0.7** 0.7** 0.7*
CPT1b 1 1 0.9 0.9
CPT2 1 0.7** 0.5** 0.6**
CD36 1 0.8* 0.7* 0.7*
FABP 1 0.8** 0.7* 0.7*
PPARα 1 0.7* 0.7* 0.7
Mitochondrial Biogenesis
PGC1α 1 N/D 1.01 1.08
PGC1β 1 N/D 0.98 0.89
(ESRRA) ERRα 1 1.4 0.6 1
TFAM 1 0.7* 1 0.9
NFR1 1 1 1 0.7
NRF2 1 0.9 1 0.8
SIRT1 1 N/D 0.69* N/D
Oxidative Phosphorylation
Ndufa9 1 0.8 0.9 0.8
Uqcrc1 1 0.7* 0.7* 0.8*
Others
UCP2 1 0.9 0.9 0.9
UCP3 1 1.2 0.8 0.5**
PDK4 1 1.5 0.3* 0.6
PDHA1 1 N/D 0.72** N/D
CKMT2 (MTCK) 1 0.7* 0.7** 0.7*
MTE1 1 0.9 0.6* 0.6*
Total RNA from six wild-type and six CIRKO hearts at each age respectively, was quantified by real-time PCR and normalized to cyclophilin expression.
Values represent fold change in mRNA levels relative to wild-type, which were assigned as 1.
*
p < 0.05;
**
p < 0.005 versus age-matched wild-type controls. N/D = not done. Full gene names are in the supplementary Table S1.
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